212 related articles for article (PubMed ID: 26512731)
1. Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.
Cruz JC; Iorio M; Monciardini P; Simone M; Brunati C; Gaspari E; Maffioli SI; Wellington E; Sosio M; Donadio S
J Nat Prod; 2015 Nov; 78(11):2642-7. PubMed ID: 26512731
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.
Simone M; Monciardini P; Gaspari E; Donadio S; Maffioli SI
J Antibiot (Tokyo); 2013 Feb; 66(2):73-8. PubMed ID: 23168402
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024.
Gallo G; Renzone G; Palazzotto E; Monciardini P; Arena S; Faddetta T; Giardina A; Alduina R; Weber T; Sangiorgi F; Russo A; Spinelli G; Sosio M; Scaloni A; Puglia AM
BMC Genomics; 2016 Jan; 17():42. PubMed ID: 26754974
[TBL] [Abstract][Full Text] [Related]
5. Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.
Maffioli SI; Monciardini P; Catacchio B; Mazzetti C; Münch D; Brunati C; Sahl HG; Donadio S
ACS Chem Biol; 2015 Apr; 10(4):1034-42. PubMed ID: 25574687
[TBL] [Abstract][Full Text] [Related]
6. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
Castiglione F; Lazzarini A; Carrano L; Corti E; Ciciliato I; Gastaldo L; Candiani P; Losi D; Marinelli F; Selva E; Parenti F
Chem Biol; 2008 Jan; 15(1):22-31. PubMed ID: 18215770
[TBL] [Abstract][Full Text] [Related]
7. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
8. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
[TBL] [Abstract][Full Text] [Related]
9. A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.
Carrano L; Abbondi M; Turconi P; Candiani G; Marinelli F
Biomed Res Int; 2015; 2015():419383. PubMed ID: 26346738
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
Lawton EM; Cotter PD; Hill C; Ross RP
FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
[TBL] [Abstract][Full Text] [Related]
11. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
Dischinger J; Josten M; Szekat C; Sahl HG; Bierbaum G
PLoS One; 2009 Aug; 4(8):e6788. PubMed ID: 19707558
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the isolation and characterization of antibacterial lantibiotics.
Jabes D; Donadio S
Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
[TBL] [Abstract][Full Text] [Related]
13. Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.
He Z; Kisla D; Zhang L; Yuan C; Green-Church KB; Yousef AE
Appl Environ Microbiol; 2007 Jan; 73(1):168-78. PubMed ID: 17071789
[TBL] [Abstract][Full Text] [Related]
14. Lantibiotics: structure, biosynthesis and mode of action.
McAuliffe O; Ross RP; Hill C
FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Escano J; Ravichandran A; Salamat B; Smith L
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
[TBL] [Abstract][Full Text] [Related]
16. Inorganic phosphate is a trigger factor for Microbispora sp. ATCC-PTA-5024 growth and NAI-107 production.
Giardina A; Alduina R; Gallo G; Monciardini P; Sosio M; Puglia AM
Microb Cell Fact; 2014 Oct; 13():133. PubMed ID: 25300322
[TBL] [Abstract][Full Text] [Related]
17. Roseocin, a novel two-component lantibiotic from an actinomycete.
Singh M; Chaudhary S; Sareen D
Mol Microbiol; 2020 Feb; 113(2):326-337. PubMed ID: 31696567
[TBL] [Abstract][Full Text] [Related]
18. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
[TBL] [Abstract][Full Text] [Related]
19. Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
Suda S; Westerbeek A; O'Connor PM; Ross RP; Hill C; Cotter PD
Chem Biol; 2010 Oct; 17(10):1151-60. PubMed ID: 21035738
[TBL] [Abstract][Full Text] [Related]
20. Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.
Valsesia G; Medaglia G; Held M; Minas W; Panke S
Appl Environ Microbiol; 2007 Mar; 73(5):1635-45. PubMed ID: 17194841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
